Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Neurodevelopmental mechanisms of schizophrenia: understanding disturbed postnatal brain maturation through neuregulin-1-ErbB4 and DISC1.

Jaaro-Peled H, Hayashi-Takagi A, Seshadri S, Kamiya A, Brandon NJ, Sawa A.

Trends Neurosci. 2009 Sep;32(9):485-95. doi: 10.1016/j.tins.2009.05.007. Epub 2009 Aug 26. Review.

2.

Disrupted-in-schizophrenia 1 and neuregulin 1 are required for the specification of oligodendrocytes and neurones in the zebrafish brain.

Wood JD, Bonath F, Kumar S, Ross CA, Cunliffe VT.

Hum Mol Genet. 2009 Feb 1;18(3):391-404. doi: 10.1093/hmg/ddn361. Epub 2008 Nov 7.

PMID:
18996920
3.

Gene models of schizophrenia: DISC1 mouse models.

Jaaro-Peled H.

Prog Brain Res. 2009;179:75-86. doi: 10.1016/S0079-6123(09)17909-8. Epub 2009 Nov 20. Review.

PMID:
20302820
4.

Neuregulin-1 signalling and antipsychotic treatment: potential therapeutic targets in a schizophrenia candidate signalling pathway.

Deng C, Pan B, Engel M, Huang XF.

Psychopharmacology (Berl). 2013 Mar;226(2):201-15. doi: 10.1007/s00213-013-3003-2. Epub 2013 Feb 7. Review.

PMID:
23389757
5.

Disrupted-in-Schizophrenia-1 expression is regulated by beta-site amyloid precursor protein cleaving enzyme-1-neuregulin cascade.

Seshadri S, Kamiya A, Yokota Y, Prikulis I, Kano S, Hayashi-Takagi A, Stanco A, Eom TY, Rao S, Ishizuka K, Wong P, Korth C, Anton ES, Sawa A.

Proc Natl Acad Sci U S A. 2010 Mar 23;107(12):5622-7. doi: 10.1073/pnas.0909284107. Epub 2010 Mar 8.

6.

Sub-chronic Antipsychotic Drug Administration Reverses the Expression of Neuregulin 1 and ErbB4 in a Cultured MK801-Induced Mouse Primary Hippocampal Neuron or a Neurodevelopmental Schizophrenia Model.

Li C, Tang Y, Yang J, Zhang X, Liu Y, Tang A.

Neurochem Res. 2016 Aug;41(8):2049-64. doi: 10.1007/s11064-016-1917-x. Epub 2016 Apr 21.

PMID:
27097547
7.

Neuregulin 1 in neural development, synaptic plasticity and schizophrenia.

Mei L, Xiong WC.

Nat Rev Neurosci. 2008 Jun;9(6):437-52. doi: 10.1038/nrn2392. Epub 2008 May 14. Review.

8.

Neuregulin 1-ErbB4-PI3K signaling in schizophrenia and phosphoinositide 3-kinase-p110δ inhibition as a potential therapeutic strategy.

Law AJ, Wang Y, Sei Y, O'Donnell P, Piantadosi P, Papaleo F, Straub RE, Huang W, Thomas CJ, Vakkalanka R, Besterman AD, Lipska BK, Hyde TM, Harrison PJ, Kleinman JE, Weinberger DR.

Proc Natl Acad Sci U S A. 2012 Jul 24;109(30):12165-70. doi: 10.1073/pnas.1206118109. Epub 2012 Jun 11.

9.

Molecular dissection of NRG1-ERBB4 signaling implicates PTPRZ1 as a potential schizophrenia susceptibility gene.

Buxbaum JD, Georgieva L, Young JJ, Plescia C, Kajiwara Y, Jiang Y, Moskvina V, Norton N, Peirce T, Williams H, Craddock NJ, Carroll L, Corfas G, Davis KL, Owen MJ, Harroch S, Sakurai T, O'Donovan MC.

Mol Psychiatry. 2008 Feb;13(2):162-72. Epub 2007 Apr 17.

10.

Epistatic and Independent Effects on Schizophrenia-Related Phenotypes Following Co-disruption of the Risk Factors Neuregulin-1 × DISC1.

O'Tuathaigh CM, Fumagalli F, Desbonnet L, Perez-Branguli F, Moloney G, Loftus S, O'Leary C, Petit E, Cox R, Tighe O, Clarke G, Lai D, Harvey RP, Cryan JF, Mitchell KJ, Dinan TG, Riva MA, Waddington JL.

Schizophr Bull. 2017 Jan;43(1):214-225. doi: 10.1093/schbul/sbw120. Epub 2016 Sep 9.

11.

Interneuronal DISC1 regulates NRG1-ErbB4 signalling and excitatory-inhibitory synapse formation in the mature cortex.

Seshadri S, Faust T, Ishizuka K, Delevich K, Chung Y, Kim SH, Cowles M, Niwa M, Jaaro-Peled H, Tomoda T, Lai C, Anton ES, Li B, Sawa A.

Nat Commun. 2015 Dec 11;6:10118. doi: 10.1038/ncomms10118.

12.

Perinatal phencyclidine treatment alters neuregulin 1/erbB4 expression and activation in later life.

du Bois TM, Newell KA, Huang XF.

Eur Neuropsychopharmacol. 2012 May;22(5):356-63. doi: 10.1016/j.euroneuro.2011.09.002. Epub 2011 Oct 1.

PMID:
21962913
13.
14.

Altered growth factor signaling pathways as the basis of aberrant stem cell maturation in schizophrenia.

Kalkman HO.

Pharmacol Ther. 2009 Jan;121(1):115-22. doi: 10.1016/j.pharmthera.2008.11.002. Epub 2008 Nov 20. Review.

PMID:
19046988
15.

Neuregulin 1-erbB4 pathway in schizophrenia: From genes to an interactome.

Banerjee A, Macdonald ML, Borgmann-Winter KE, Hahn CG.

Brain Res Bull. 2010 Sep 30;83(3-4):132-9. doi: 10.1016/j.brainresbull.2010.04.011. Epub 2010 Apr 28. Review.

16.

Expressions of neuregulin 1beta and ErbB4 in prefrontal cortex and hippocampus of a rat schizophrenia model induced by chronic MK-801 administration.

Feng Y, Wang XD, Guo CM, Yang Y, Li JT, Su YA, Si TM.

J Biomed Biotechnol. 2010;2010:859516. doi: 10.1155/2010/859516. Epub 2010 May 4.

17.

Mechanisms of neuregulin action.

Talmage DA.

Novartis Found Symp. 2008;289:74-84; discussion 84-93. Review.

18.

Schizophrenia susceptibility pathway neuregulin 1-ErbB4 suppresses Src upregulation of NMDA receptors.

Pitcher GM, Kalia LV, Ng D, Goodfellow NM, Yee KT, Lambe EK, Salter MW.

Nat Med. 2011 Apr;17(4):470-8. doi: 10.1038/nm.2315. Epub 2011 Mar 27.

19.

Convergent evidence that oligodendrocyte lineage transcription factor 2 (OLIG2) and interacting genes influence susceptibility to schizophrenia.

Georgieva L, Moskvina V, Peirce T, Norton N, Bray NJ, Jones L, Holmans P, Macgregor S, Zammit S, Wilkinson J, Williams H, Nikolov I, Williams N, Ivanov D, Davis KL, Haroutunian V, Buxbaum JD, Craddock N, Kirov G, Owen MJ, O'Donovan MC.

Proc Natl Acad Sci U S A. 2006 Aug 15;103(33):12469-74. Epub 2006 Aug 4.

20.

The neuregulin-I/ErbB signaling system in development and disease.

Britsch S.

Adv Anat Embryol Cell Biol. 2007;190:1-65. Review.

PMID:
17432114

Supplemental Content

Support Center